Concepedia

Author

Paul Chervinsky

Allergy Associates Research Center

Also Known As

P CHERVINSKY, P Chervinsky, P. Chervinsky, PAUL CHERVINSKY, Paul Chervinsky, Paul S. Chervinsky

101

Publications

4.5K

Citations

34

H-Index

40

Concepts

All Affiliations

Allergy Associates Research CenterMedical Research AssociatesNew England Research (United States)Research Triangle Park FoundationCalifornia Allergy and Asthma Medical Group
PC

About

Paul Chervinsky is an author at Allergy Associates Research Center specializing in medicine, asthma, and allergy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

27

44

2.6K

2

Allergy

21

32

1.8K

3

Allergy Medicine

17

20

1.1K

4

Immunology

3

3

336

5

Endocrinology

1

1

80

Paul Chervinsky

×

63

Publications

4.4K

Citations

34

H-Index

YearCitations

A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma

David S. Pearlman, Paul Chervinsky, Craig LaForce,

New England Journal of Medicine

1992

362

Montelukast Added to Inhaled Beclomethasone in Treatment of Asthma

Michel Laviolette, Kerstin Malmström, Susan Lu,

American Journal of Respiratory and Critical Care Medicine

1999

353

Detection of Growth Suppression in Children During Treatment With Intranasal Beclomethasone Dipropionate

David P. Skoner, Gary S. Rachelefsky, Eli O. Meltzer,

PEDIATRICS

2000

304

Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis

Paul Chervinsky, Thomas B. Casale, Robert G. Townley,

Annals of Allergy Asthma & Immunology

2003

210

Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma

William W. Busse, Paul Chervinsky, John J. Condemi,

Journal of Allergy and Clinical Immunology

1998

185

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life.

Michael Noonan, Paul Chervinsky, William W. Busse,

American Journal of Respiratory and Critical Care Medicine

1995

183

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group

M.J. Noonan, Paul Chervinsky, M. Brandon,

European Respiratory Journal

1998

175

Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma

Jonathan Corren, Alan G. Harris, Donald W. Aaronson,

Journal of Allergy and Clinical Immunology

1997

175

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma

T REISS, Paul Chervinsky, Againdra K. Bewtra,

Journal of Allergy and Clinical Immunology

1996

166

Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma

Paul Chervinsky, Andre van As, Edwin A. Bronsky,

Journal of Allergy and Clinical Immunology

1994

165

Page 1